Kanidi Biotech Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.86 M
- Revenue Growth 4.86%
- Profit Growth -188.48%
- Ebitda 105.53%
- Total Assets 51.12%
About Kanidi Biotech Llp
Kanidi Biotech Llp (KBL) is 14 Year, 1 Month old Limited Liability Partnership 05 January 2011. Its registered office is in South West Delhi, Delhi, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN/FCRN
AAA-3304
- Incorporation Date
05 Jan 2011
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Delhi
- Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Kanidi Biotech Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Passi  | Designated Partner | 05-Jan-2011 | Current |
| Dipin Passi | Designated Partner | 05-Jan-2011 | Current |
Financial Performance of Kanidi Biotech Llp.
Kanidi Biotech Llp, for the financial year ended 2021, experienced modest growth in revenue, with a 4.86% increase. The company also saw a substantial fall in profitability, with a 188.48% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kanidi Biotech Llp?
Unlock access to Kanidi Biotech Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vedicare Ayurveda Private LimitedNitin Passi and Dipin Passi are mutual person
Lotus Herbals Private LimitedNitin Passi and Dipin Passi are mutual person
Evershine Garments LlpNitin Passi and Dipin Passi are mutual person
- Veritasx Llp
Dipin Passi is a mutual person
Charges (Loans)
₹0.86 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Nov 2021 | Hdfc Bank Limited | ₹0.86 M | Open |
How Many Employees Work at Kanidi Biotech Llp?
Kanidi Biotech Llp has a workforce of 47 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kanidi Biotech Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kanidi Biotech Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
